Vertex Pharmaceuticals EVP Ourania Tatsis sold 3,242 shares worth $1.62 million under a pre-arranged plan. The sale, executed on March 10, 2025, priced each share at $499.99, with Tatsis still holding ...

NEW YORK CITY, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

Viatris issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods. The most recent guidance for Viatris (VTRS) was reported ...

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...

Viatris Inc. (VTRS) recently reported a fourth quarter that fell short of Wall Street expectations, missing revenue and ...

Viatris emerged from Pfizer's merger with Mylan and Upjohn, trading since 2020, with a market cap of $11 billion. See why I ...

Random Walk Theory is wrong. If price were random, there would not be support or resistance levels. The Viatris (VTRS) shows there are.

WASHINGTON (Reuters) - U.S. Agency for International Development workers were allowed to briefly reenter the headquarters in ...

Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital ...

Shares are trading down in response to the disappointing results. VTRS’ share price has dropped 4.8% year to date compared with the industry’s 16.6% decline. All growth rates mentioned below are on a ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...